Desk›Healthcare› Dr Agarwals Eye Hospital Ltd
Dr Agarwals Eye Hospital Ltd
BSE 526783 · NSE DRAGARWQ · ISIN INE934C01018 · Group B · Active
Healthcare › Healthcare › Healthcare Services › Hospital
₹5,176.70
-1.39%
BSE close, 28 August 2026
₹2,501.81 cr
0.5 cr shares · Micro cap
₹616.30 cr
as published
32.8× · 13.59×
EPS ₹157.71 · BV ₹380.92
470.87 / 70.10
₹ cr, as filed
14
5 selected · 36%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -19.0% |
|---|---|
| Against 52-week low | +22.4% |
| Day change | -1.39% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹157.71 |
|---|---|
| Price / earnings | 32.82× |
| Price / book | 13.59× |
| Book value — derived, price ÷ P/B | ₹380.92 |
| Return on equity | 41.41% |
| Operating margin | 31.63% |
| Net margin | 16.35% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 41.41%
- ROE as published
- 41.41%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 142.97 | 23.38 | 48.38 | 31.63% | 16.35% |
| Mar-26 · Q | 120.01 | 16.24 | 33.60 | 29.41% | 13.53% |
| FY25-26 | 470.87 | 70.10 | 147.02 | 32.10% | 14.89% |
Quarter on quarter
- Revenue, quarter on quarter
- +19.1%
- Net profit, quarter on quarter
- +44.0%
- Operating margin, quarter on quarter
- +222 bps
Disclosure profile 14 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Change in Management | 1 |
| Press Release | 1 |
| Results | 1 |
| Scheme of Arrangement | 1 |
| Selected sub-total | 5 |
| Procedural | |
| AGM / EGM | 3 |
| Annual Report | 1 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| Newspaper Publication | 1 |
| Record Date | 1 |
| Trading Window | 1 |
| Procedural sub-total | 9 |
| Total | 14 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
14 filings · 5 selected · busiest 2026-08-03 and 2026-08-14
Filing rhythm · the twelve most recent
2026-08-032026-10-08
SelectedProcedural
Filings
14 in the window · 8 earlier on record
-
8 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Disclosure under Regulation 74(5) of the SEBI (DP) Regulations, 2018, is submitted.
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
5 October 2026 ·
Scheme of Arrangement
Receipt of sanction from the Honble NCLT, Chennai bench towards the Scheme of Amalgamation between Dr. Agarwals Eye Hospital Limited and Dr. Agarwals Health Care Limited and its respective ....
Company Update / Scheme of Arrangement View filing →
-
28 September 2026 ·
Closure of Trading Window
The disclosure on closure of trading window is submitted.
Insider Trading / SAST / Closure of Trading Window View filing →
-
10 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
32nd Annual General Meeting (AGM)- Results of the remote e-voting and e-voting during the AGM along with the Scrutinizer report, is submitted.
AGM/EGM / AGM View filing →
-
9 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Summary of proceedings of the 32nd Annual General Meeting of the Company held on September 09, 2026, is submitted.
AGM/EGM / AGM View filing →
-
27 August 2026 ·
Press Release / Media Release
Media Release - Launch of World's first Pinhole Pupilloplasty (PPP) Centre by the Company, is submitted.
Company Update / Press Release / Media Release View filing →
-
14 August 2026 ·
32Nd Annual General Meeting Of The Members Of The Company- September 09, 2026
Notice convening the 32nd Annual General Meeting of the members of the Company which is scheduled to be held on September 09, 2026, is submitted.
AGM/EGM / AGM View filing →
-
14 August 2026 ·
Intimation Of Record Date Under Regulation 42 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
The record date for the payment of final dividend for the financial year 2025-26 is submitted.
Corp. Action / Record Date View filing →
-
14 August 2026 ·
Reg. 34 (1) Annual Report.
Annual Report of Dr. Agarwal's Eye Hospital Limited for the financial year 2025-26 is submitted
Others / Reg. 34 (1) Annual Report View filing →
-
3 August 2026 ·
Change in Management
Reappointment of cost auditors to conduct audit of the cost records of the Company for the financial year 2026-27, is submitted.
Company Update / Change in Management View filing →
-
3 August 2026 ·
Results- Unaudited Financial Results For The Quarter Ended June 30, 2026
Unaudited Financial Results for the quarter ended June 30, 2026, is submitted.
Result / Financial Results View filing →
-
3 August 2026 ·
Board Meeting Outcome for Outcome Of The Board Meeting Held On August 03, 2026
Outcome of the proceedings of the Board Meeting held on August 03, 2026 is submitted.
Board Meeting / Outcome of Board Meeting View filing →
-
28 July 2026 ·
Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results For The Quarter Ended June 30, 2026
Dr Agarwals Eye Hospital Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2026 ,inter alia, to consider and approve the unaudited financial ....
Board Meeting / Board Meeting View filing →
-
20 July 2026 ·
Newspaper Publication
Newspaper Advertisement of the Notice of Hearing of the Company's Petition in relation to the Scheme of Amalgamation between Dr. Agarwal's Eye Hospital Limited and Dr. Agarwal's Health ....
Company Update / Newspaper Publication View filing →
RSS feed for Dr Agarwals Eye Hospital Ltd · the 50 most recent filings